FDA Expands Clinical Trial Eligibility for Cancer Patients (oncologynewscentral.com)
The FDA has broadened clinical trial eligibility to include more cancer patients, aiming to enhance treatment options and research diversity.
More cancer patients may become eligible for clinical trials. New FDA guidance encourages broader eligibility criteria, potentially opening studies to patients previously excluded because of health status & results.
www.oncologynewscentral.com/oncology/fda...
